New drugs treat kidney and stomach cancer

Molecular model of Sutent, previously known as SU- 11248 (Photo: gistsupport / VNE)

The special effect of Sutent during the well-developed experimental treatment of stomach cancer and kidney cancer has led the FDA to decide to shorten the time to test and put the drug into early treatment for patients.

Sutent works to prevent blood and nutrients needed to nourish cancer cells.

The experimental treatment showed that the dose of a Sutent tablet a day, cancer tissues were reduced and retarded in cancer patients. Side effects of this medicine are causing diarrhea, skin discoloration, dry mouth and reduced taste.

VNA The US Federal Food and Drug Administration (FDA) has approved the introduction of a new drug Sutent, manufactured by US pharmaceutical company Pfizer, for the treatment of kidney cancer and stomach cancer.